Aart H. Bootsma

2.5k total citations · 1 hit paper
22 papers, 1.8k citations indexed

About

Aart H. Bootsma is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Aart H. Bootsma has authored 22 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Epidemiology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Aart H. Bootsma's work include Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Blood Pressure and Hypertension Studies (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Aart H. Bootsma is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Blood Pressure and Hypertension Studies (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Aart H. Bootsma collaborates with scholars based in Netherlands, United Kingdom and Denmark. Aart H. Bootsma's co-authors include Steven W. J. Lamberts, Loes Lanting, Inez M.A. Joung, Johan P. Mackenbach, Per Hildebrandt, Christian Torp‐Pedersen, Anders Hamsten, Markku Laakso, Miles Fisher and Lars Rydén and has published in prestigious journals such as The Lancet, Annals of Internal Medicine and Diabetes Care.

In The Last Decade

Aart H. Bootsma

22 papers receiving 1.7k citations

Hit Papers

Intense metabolic control by means of insulin in patients... 2005 2026 2012 2019 2005 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aart H. Bootsma Netherlands 16 1.1k 548 418 230 210 22 1.8k
Umberto Valentini Italy 26 1.4k 1.3× 425 0.8× 333 0.8× 221 1.0× 351 1.7× 53 2.6k
Ken Gu Singapore 9 993 0.9× 498 0.9× 300 0.7× 194 0.8× 272 1.3× 13 1.7k
W. Gatling United Kingdom 21 1.2k 1.1× 440 0.8× 288 0.7× 309 1.3× 349 1.7× 38 1.9k
Esther M. Briganti Australia 23 537 0.5× 476 0.9× 232 0.6× 217 0.9× 347 1.7× 38 2.8k
Tim Welborn Australia 6 1.0k 0.9× 330 0.6× 300 0.7× 200 0.9× 195 0.9× 9 1.8k
Michele Sacco Italy 26 1.3k 1.1× 638 1.2× 318 0.8× 353 1.5× 488 2.3× 80 2.8k
Steven J. Bowlin United States 19 764 0.7× 256 0.5× 240 0.6× 168 0.7× 383 1.8× 27 1.9k
Frank Schäper Germany 25 765 0.7× 520 0.9× 221 0.5× 394 1.7× 319 1.5× 52 1.9k
Tripthi Kamath United States 11 840 0.8× 567 1.0× 403 1.0× 167 0.7× 289 1.4× 22 2.0k
Jan Cederholm Sweden 31 1.9k 1.8× 738 1.3× 378 0.9× 516 2.2× 450 2.1× 76 2.9k

Countries citing papers authored by Aart H. Bootsma

Since Specialization
Citations

This map shows the geographic impact of Aart H. Bootsma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aart H. Bootsma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aart H. Bootsma more than expected).

Fields of papers citing papers by Aart H. Bootsma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aart H. Bootsma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aart H. Bootsma. The network helps show where Aart H. Bootsma may publish in the future.

Co-authorship network of co-authors of Aart H. Bootsma

This figure shows the co-authorship network connecting the top 25 collaborators of Aart H. Bootsma. A scholar is included among the top collaborators of Aart H. Bootsma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aart H. Bootsma. Aart H. Bootsma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lucassen, Eliane A., Aart H. Bootsma, & Maria J. Overbeek. (2018). Pancreatitis as the presenting symptom of abdominal sarcoidosis.. PubMed. 76(2). 84–86. 2 indexed citations
2.
Blankenstein, Annette H., Jan L.C.M. van Saase, Paul Van Daele, et al.. (2015). Training specialists to write appropriate reply letters to general practitioners about patients with medically unexplained physical symptoms; A cluster-randomized trial.. Patient Education and Counseling. 98(10). 1229–1235. 5 indexed citations
3.
Lanting, Loes, Inez M.A. Joung, Ineke Vogel, et al.. (2008). Ethnic differences in outcomes of diabetes care and the role of self-management behavior. Patient Education and Counseling. 72(1). 146–154. 41 indexed citations
4.
Lanting, Loes, Aart H. Bootsma, Steven W. J. Lamberts, Johan P. Mackenbach, & Inez M.A. Joung. (2008). Ethnic differences in Internal Medicine referrals and diagnosis in the Netherlands. BMC Public Health. 8(1). 287–287. 16 indexed citations
5.
Hattem, S. van, Aart H. Bootsma, & Hok Bing Thio. (2008). Skin manifestations of diabetes. Cleveland Clinic Journal of Medicine. 75(11). 772–787. 66 indexed citations
6.
Zandbergen, Adrienne A.M., Liffert Vogt, Dick de Zeeuw, et al.. (2007). Change in Albuminuria Is Predictive of Cardiovascular Outcome in Normotensive Patients With Type 2 Diabetes and Microalbuminuria. Diabetes Care. 30(12). 3119–3121. 17 indexed citations
7.
Zandbergen, Adrienne A.M., Steven W. J. Lamberts, M.G.A. Baggen, et al.. (2006). The IGF‐I system and the renal and haemodynamic effects of losartan in normotensive patients with type 2 diabetes mellitus: a randomized clinical trial. Clinical Endocrinology. 64(2). 203–208. 5 indexed citations
8.
Zandbergen, Adrienne A.M., Steven W. J. Lamberts, J. A. M. J. L. Janssen, & Aart H. Bootsma. (2006). Short-term administration of an angiotensin-receptor antagonist in patients with impaired fasting glucose improves insulin sensitivity and increases free IGF-I. European Journal of Endocrinology. 155(2). 293–296. 15 indexed citations
9.
Zandbergen, Adrienne A.M., Eric J.G. Sijbrands, Steven W. J. Lamberts, & Aart H. Bootsma. (2006). Normotensive Women With Type 2 Diabetes and Microalbuminuria Are at High Risk for Macrovascular Disease. Diabetes Care. 29(8). 1851–1855. 15 indexed citations
10.
Gustafsson, Finn, Klas Malmberg, Lars Rydén, et al.. (2006). [Metabolic control by means of insulin in patients with type 2 diabetes and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity--secondary publication].. PubMed. 168(6). 581–4. 1 indexed citations
11.
Lanting, Loes, Inez M.A. Joung, Johan P. Mackenbach, Steven W. J. Lamberts, & Aart H. Bootsma. (2005). Ethnic Differences in Mortality, End-Stage Complications, and Quality of Care Among Diabetic Patients. Diabetes Care. 28(9). 2280–2288. 316 indexed citations
12.
Schram, Miranda T., Casper G. Schalkwijk, Aart H. Bootsma, et al.. (2005). Advanced Glycation End Products Are Associated With Pulse Pressure in Type 1 Diabetes. Hypertension. 46(1). 232–237. 92 indexed citations
13.
Malmberg, K., Lars Rydén, Hans Wedel, et al.. (2005). Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. European Heart Journal. 26(7). 650–661. 728 indexed citations breakdown →
14.
Dallinga‐Thie, Geesje M., et al.. (2004). Atorvastatin Decreases Apolipoprotein C-III in Apolipoprotein B-Containing Lipoprotein and HDL in Type 2 Diabetes. Diabetes Care. 27(6). 1358–1364. 41 indexed citations
15.
Zandbergen, Adrienne A.M., M.G.A. Baggen, Steven W. J. Lamberts, et al.. (2003). Effect of Losartan on Microalbuminuria in Normotensive Patients with Type 2 Diabetes Mellitus. Annals of Internal Medicine. 139(2). 90–96. 51 indexed citations
16.
Hoogerbrugge, Nicoline, et al.. (2003). Atorvastatin Dose-Dependently Decreases Hepatic Lipase Activity in Type 2 Diabetes. Diabetes Care. 26(2). 427–432. 44 indexed citations
17.
Berns, Els M.J.J., Annelies de Klein, Wim L.J. van Putten, et al.. (1995). Association between rb‐1 gene alterations and factors of favourable prognosis in human breast cancer, without effect on survival. International Journal of Cancer. 64(2). 140–145. 24 indexed citations
18.
Eijck, Casper H.J. van, J Jeekel, E. P. Krenning, et al.. (1994). Somatostatin-receptor scintigraphy in primary breast cancer. The Lancet. 343(8898). 640–643. 98 indexed citations
19.
Bootsma, Aart H., Steven W. J. Lamberts, Casper H.J. van Eijck, et al.. (1993). Somatostatin receptor‐positive primary breast tumors: Genetic, patient and tumor characteristics. International Journal of Cancer. 54(3). 357–362. 19 indexed citations
20.
Bootsma, Aart H., Annelies de Klein, Jean Claude Reubi, Ellen C. Zwarthoff, & S. W. J. Lamberts. (1990). Genetic changes in somatostatin receptor positive breast tumors. The Journal of Steroid Biochemistry and Molecular Biology. 37(6). 829–832. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026